168 related articles for article (PubMed ID: 29755299)
1.
Fukumitsu N; Yeh SH; Flores Ii LG; Mukhopadhyay U; Young D; Ogawa K; Jeong HJ; Tong W; Gelovani JG
Contrast Media Mol Imaging; 2018; 2018():3612027. PubMed ID: 29755299
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain.
Reid AE; Hooker J; Shumay E; Logan J; Shea C; Kim SW; Collins S; Xu Y; Volkow N; Fowler JS
Nucl Med Biol; 2009 Apr; 36(3):247-58. PubMed ID: 19324270
[TBL] [Abstract][Full Text] [Related]
3.
Yeh SH; Lin MH; Leo Garcia Flores II; Mukhopadhyay U; Young D; Ogawa K; Jeong JH; Tong W; Gelovani JG; Fukumitsu N
Mol Imaging; 2021; 2021():6660358. PubMed ID: 33867871
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.
Seo YJ; Muench L; Reid A; Chen J; Kang Y; Hooker JM; Volkow ND; Fowler JS; Kim SW
Bioorg Med Chem Lett; 2013 Dec; 23(24):6700-5. PubMed ID: 24210501
[TBL] [Abstract][Full Text] [Related]
5. Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹⁸F-FAHA.
Yeh HH; Tian M; Hinz R; Young D; Shavrin A; Mukhapadhyay U; Flores LG; Balatoni J; Soghomonyan S; Jeong HJ; Pal A; Uthamanthil R; Jackson JN; Nishii R; Mizuma H; Onoe H; Kagawa S; Higashi T; Fukumitsu N; Alauddin M; Tong W; Herholz K; Gelovani JG
Neuroimage; 2013 Jan; 64():630-9. PubMed ID: 22995777
[TBL] [Abstract][Full Text] [Related]
6. In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).
Hendricks JA; Keliher EJ; Marinelli B; Reiner T; Weissleder R; Mazitschek R
J Med Chem; 2011 Aug; 54(15):5576-82. PubMed ID: 21721525
[TBL] [Abstract][Full Text] [Related]
7. Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.
Bonomi R; Mukhopadhyay U; Shavrin A; Yeh HH; Majhi A; Dewage SW; Najjar A; Lu X; Cisneros GA; Tong WP; Alauddin MM; Liu RS; Mangner TJ; Turkman N; Gelovani JG
PLoS One; 2015; 10(8):e0133512. PubMed ID: 26244761
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial.
Kuo PH; Carlson KR; Christensen I; Girardi M; Heald PW
Mol Imaging Biol; 2008; 10(6):306-14. PubMed ID: 18665425
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer's Disease.
Chen YA; Lu CH; Ke CC; Chiu SJ; Chang CW; Yang BH; Gelovani JG; Liu RS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445342
[TBL] [Abstract][Full Text] [Related]
11. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
Zeglis BM; Pillarsetty N; Divilov V; Blasberg RA; Lewis JS
Nucl Med Biol; 2011 Jul; 38(5):683-96. PubMed ID: 21718944
[TBL] [Abstract][Full Text] [Related]
12. Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model.
Tang W; Kuruvilla SA; Galitovskiy V; Pan ML; Grando SA; Mukherjee J
Am J Nucl Med Mol Imaging; 2014; 4(4):324-32. PubMed ID: 24982818
[TBL] [Abstract][Full Text] [Related]
13. A Novel PET Probe for Brown Adipose Tissue Imaging in Rodents.
Wang H; Wang M; Chansaenpak K; Liu Y; Yuan H; Xie J; Yin H; Branca RT; Li Z; Wu Z
Mol Imaging Biol; 2020 Jun; 22(3):675-684. PubMed ID: 31520279
[TBL] [Abstract][Full Text] [Related]
14. [18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity.
Shirakawa T; Mitsuoka K; Kuroda K; Miyoshi S; Shiraki K; Naraoka H; Noda A; Fujikawa A; Fujiwara M
Toxicol Sci; 2013 May; 133(1):13-21. PubMed ID: 23457119
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
16. High-Contrast PET Imaging with [
Turkman N; Xu S; Huang CH; Eyermann C; Salino J; Khan P
J Med Chem; 2023 Apr; 66(8):5611-5621. PubMed ID: 37068265
[TBL] [Abstract][Full Text] [Related]
17. Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells.
Moku G; Vangala S; Yakati V; Gali CC; Saha S; Madamsetty VS; Vyas A
Anticancer Agents Med Chem; 2022; 22(5):914-925. PubMed ID: 34488592
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
Carbajo-García MC; García-Alcázar Z; Corachán A; Monleón J; Trelis A; Faus A; Pellicer A; Ferrero H
Fertil Steril; 2022 Feb; 117(2):433-443. PubMed ID: 34809976
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of histone deacetylases in the inhibition of mammary carcinogenesis by dietary energy restriction (DER): effects of suberoylanilide hydroxamic acid (SAHA) and DER in a rat model.
Zhu Z; Jiang W; McGinley JN; Thompson HJ
Cancer Prev Res (Phila); 2013 Apr; 6(4):290-8. PubMed ID: 23365133
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]